IDH1 and astrocytoma (excluding glioblastoma): This observation prompted the World Health Organization (WHO) to consider IDH‐mutated GB as IDH‐mutated grade 4 astrocytomas in its updated classification, to improve their distinction from IDH‐wildtype GB [6, 7].